JP5248733B2 - 揮散防止型固形製剤およびその製造方法 - Google Patents

揮散防止型固形製剤およびその製造方法 Download PDF

Info

Publication number
JP5248733B2
JP5248733B2 JP2003399851A JP2003399851A JP5248733B2 JP 5248733 B2 JP5248733 B2 JP 5248733B2 JP 2003399851 A JP2003399851 A JP 2003399851A JP 2003399851 A JP2003399851 A JP 2003399851A JP 5248733 B2 JP5248733 B2 JP 5248733B2
Authority
JP
Japan
Prior art keywords
solid preparation
volatilization
tablet
preventing
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003399851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005162619A (ja
Inventor
信男 宮台
敏彰 堀江
英芳 神戸
敏明 倉住
悌治 村田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP2003399851A priority Critical patent/JP5248733B2/ja
Priority to TW093134088A priority patent/TW200518774A/zh
Priority to KR1020040097230A priority patent/KR20050052361A/ko
Priority to CNA2004100961166A priority patent/CN1636553A/zh
Publication of JP2005162619A publication Critical patent/JP2005162619A/ja
Application granted granted Critical
Publication of JP5248733B2 publication Critical patent/JP5248733B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003399851A 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法 Expired - Lifetime JP5248733B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003399851A JP5248733B2 (ja) 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法
TW093134088A TW200518774A (en) 2003-11-28 2004-11-09 Volatile proof solid preparation and producing method thereof
KR1020040097230A KR20050052361A (ko) 2003-11-28 2004-11-25 휘산방지형 고형제제 및 그의 제조방법
CNA2004100961166A CN1636553A (zh) 2003-11-28 2004-11-26 防挥发型固体制剂及其制造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003399851A JP5248733B2 (ja) 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010129889A Division JP2010189443A (ja) 2010-06-07 2010-06-07 揮散防止型固形製剤およびその製造方法

Publications (2)

Publication Number Publication Date
JP2005162619A JP2005162619A (ja) 2005-06-23
JP5248733B2 true JP5248733B2 (ja) 2013-07-31

Family

ID=34724286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003399851A Expired - Lifetime JP5248733B2 (ja) 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法

Country Status (4)

Country Link
JP (1) JP5248733B2 (enrdf_load_stackoverflow)
KR (1) KR20050052361A (enrdf_load_stackoverflow)
CN (1) CN1636553A (enrdf_load_stackoverflow)
TW (1) TW200518774A (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101318032B1 (ko) * 2005-05-20 2013-10-14 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
JP2007131561A (ja) * 2005-11-09 2007-05-31 Ss Pharmaceut Co Ltd 経口固形製剤及びその製造法
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
TWI392505B (zh) * 2006-11-22 2013-04-11 Ssp Co Ltd 固形組合物
JP2008127350A (ja) * 2006-11-22 2008-06-05 Ss Pharmaceut Co Ltd 臭いを防止した固形組成物
TWI482641B (zh) 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
BRPI0719395C1 (pt) * 2006-12-07 2021-05-25 Daiichi Sankyo Co Ltd tablete revestido de filme
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
KR102209574B1 (ko) * 2019-10-08 2021-02-01 주식회사 에스엔비아 싸이올 화합물 소취용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129138A (ja) * 1984-11-16 1986-06-17 Takeda Chem Ind Ltd 被覆製剤
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
JP2591235B2 (ja) * 1989-03-30 1997-03-19 吉富製薬株式会社 アルキルシステインまたはその酸付加塩を含有する安定な錠剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH0656677A (ja) * 1992-08-03 1994-03-01 Lion Corp 制酸剤組成物
JPH08310953A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形組成物
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung

Also Published As

Publication number Publication date
JP2005162619A (ja) 2005-06-23
CN1636553A (zh) 2005-07-13
TWI333421B (enrdf_load_stackoverflow) 2010-11-21
KR20050052361A (ko) 2005-06-02
TW200518774A (en) 2005-06-16

Similar Documents

Publication Publication Date Title
JP5166876B2 (ja) 光安定性に優れた医薬製剤
JP5278708B2 (ja) ナテグリニド含有親水性医薬製剤
JP5798642B2 (ja) 経口用医薬組成物
JP5201819B2 (ja) 固形組成物
JP2018039823A (ja) メントールウィスカーの析出を抑制する方法
JP5248733B2 (ja) 揮散防止型固形製剤およびその製造方法
JP2010189443A (ja) 揮散防止型固形製剤およびその製造方法
JP6367042B2 (ja) ボリコナゾールを含む医薬組成物
JP2002522377A (ja) イブプロフェンおよびドンペリドンを含んで成る製薬組成物
JP2017119714A (ja) メドキソミル基を有するプロドラッグを含有するフィルムコーティング製剤
JPWO2007046411A1 (ja) イソキサゾール化合物の安定化方法
JP6106359B2 (ja) ロキソプロフェンナトリウムとビタミンｂ１を含有する固形製剤
JP4171204B2 (ja) 成分の昇華を抑制した経口固形製剤
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
JP6461496B2 (ja) 解熱鎮痛製剤
WO2020111089A1 (ja) 医薬組成物
JP2020183382A (ja) フィンゴリモド塩酸塩含有製剤及びフィンゴリモド塩酸塩含有製剤の製造方法
JP2001354566A (ja) ニセルゴリンの錠剤
JP6433400B2 (ja) ＨＭＧ−ＣｏＡレダクターゼ阻害薬を含有する医薬製剤
JP5065519B1 (ja) 結晶性アトルバスタチンカルシウム含有錠剤の製造方法
JP6654682B2 (ja) 解熱鎮痛医薬品
HK1076754A (en) Volatile proof solid preparation and producing method thereof
JPWO2003059337A1 (ja) ２，２−ジクロロ−１２−（４−クロロフェニル）−ドデカン酸含有医薬組成物
JP2015212259A (ja) ロスバスタチンまたはその塩の安定化製剤
JP2006257068A (ja) 高含量塩酸テルビナフィン錠剤およびその製造方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060915

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091222

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20091222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091222

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100607

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100713

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20100917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130411

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5248733

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160419

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term